GNH USA

Europe — EMA

Multimel N7-1000 E

GNH USA supplies Multimel N7-1000 E (amino acids), a nutrition supplement for parenteral nutrition in critical care and postoperative patients.

Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin

Request sourcing

1
Pack/s

What is Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin?

Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serine, the active ingredients in Multimel N7-1000 E, are nutrition supplements presented as an intravenous solution for clinical use. It supports metabolic needs and protein synthesis in patients requiring parenteral nutrition.

GNH USA supplies Multimel N7-1000 E as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.

What is Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin used for?

Multimel N7-1000 E is used as part of parenteral nutrition regimens to address protein and amino‑acid requirements in several clinical situations.

- Total parenteral nutrition (TPN): provides essential amino acids for patients unable to receive enteral feeding. - Post‑operative recovery: supports protein synthesis and wound healing after major surgery. - Critical illness or severe burns: helps meet the increased metabolic demand and prevents catabolism.

What are the side effects of Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin?

Common Side Effects: - Infusion site irritation: mild redness or discomfort at the catheter site. - Transient hypernatremia: slight increase in serum sodium levels. - Elevated blood urea nitrogen: temporary rise reflecting amino‑acid metabolism.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergy requiring immediate medical intervention. - Hyperammonemia: excessive ammonia accumulation, especially in liver‑impaired patients. - Metabolic acidosis: rare disturbance of blood pH due to altered acid‑base balance.

What precautions apply to Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin?

Multimel N7-1000 E should be used with clinical monitoring and consideration of patient‑specific factors. - Renal impairment: monitor nitrogen waste and adjust infusion rate. - Liver dysfunction: assess ammonia levels and limit amino‑acid load. - Electrolyte balance: watch for hyperkalemia or other shifts during therapy. - Pregnancy and lactation: administer only if clearly indicated and benefits outweigh risks. - Concomitant high protein intake: avoid excessive total protein to prevent overload. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin interact with?

Multimel N7-1000 E may interact with other therapies that affect nitrogen balance or electrolytes.

Major Interactions (Avoid): - Concurrent high‑dose amino‑acid solutions: risk of nitrogen overload and metabolic imbalance. - Renal replacement therapy: altered clearance may require dosage adjustment. - Certain diuretics (e.g., loop diuretics): can exacerbate electrolyte disturbances.

Moderate Interactions (Monitor Closely): - Insulin therapy: amino acids may influence glucose control. - Corticosteroids: may increase protein catabolism, affecting net benefit. - Electrolyte supplements: risk of combined electrolyte shifts requiring monitoring.

Frequently asked questions

What is Multimel N7-1000 E used for?+
Multimel N7-1000 E is an intravenous amino‑acid formulation used as part of total parenteral nutrition. It provides essential and non‑essential amino acids to patients who cannot receive nutrition orally or enterally, such as those in intensive care, after major surgery, or with severe burns.
How does the amino‑acid blend in Multimel N7-1000 E work?+
The blend supplies the body’s fundamental building blocks for protein synthesis, restores nitrogen balance, and supports cellular metabolism. Delivered directly into the bloodstream, the amino acids become immediately available for tissue repair, immune function, and energy production, especially when oral intake is impossible.
What is the usual dose of Multimel N7-1000 E?+
The prescribed dose of Multimel N7-1000 E is determined by the treating clinician based on the patient’s weight, clinical condition, renal and hepatic function, and overall nutritional goals. Healthcare professionals calculate the infusion rate to meet individual amino‑acid requirements.
Is Multimel N7-1000 E safe during pregnancy or breastfeeding?+
Use of Multimel N7-1000 E in pregnancy or while breastfeeding should only occur when clearly indicated and after a risk‑benefit assessment by the prescriber. Limited data are available, so it is generally reserved for situations where the mother cannot meet nutritional needs by other means.
How do I order Multimel N7-1000 E from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.
How does Multimel N7-1000 E compare with other parenteral amino‑acid products?+
Multimel N7-1000 E offers a balanced mixture of ten essential and non‑essential amino acids in a single intravenous formulation, matching the profile of many standard TPN solutions. Compared with products that contain additional electrolytes or vitamins, Multimel focuses solely on amino‑acid provision, allowing clinicians to tailor other components separately.
What are the storage and handling requirements for Multimel N7-1000 E?+
The product must be stored at 2‑8 °C, protected from light, and kept in its original sealed container. Do not freeze or shake the solution. Before administration, inspect for particulate matter or discoloration and allow the solution to reach room temperature if required by the infusion protocol.
How is Multimel N7-1000 E administered?+
Multimel N7-1000 E is administered intravenously, typically via a central venous catheter as part of a total parenteral nutrition regimen. The infusion rate is set by the healthcare team according to the patient’s calculated amino‑acid needs and monitored throughout the therapy.
What are the most serious risks associated with Multimel N7-1000 E?+
Serious risks include anaphylactic reactions, hyperammonemia (especially in patients with liver dysfunction), and metabolic acidosis. Prompt recognition of these events and immediate medical intervention are essential. Regular laboratory monitoring helps mitigate these risks.
Who should not receive Multimel N7-1000 E?+
Patients with known hypersensitivity to any of the amino‑acid components, severe hepatic failure with uncontrolled ammonia levels, or those for whom a balanced oral/enteral nutrition plan is feasible should generally avoid this product. Clinical judgment is required for each individual case.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin
Route
Intravenous Use
Manufacturer
Baxter Polska Sp Z O.O.
Origin
EU